Elucidating the Neuroprotective Role of PPARs in Parkinson's Disease: A Neoteric and Prospective Target.

导出 OA

翻译打印收藏纠错

作者： Tapan,Behl ^[1] ; Piyush,Madaan ^[1] ; Aayush,Sehgal ^[1] ; Sukhbir,Singh ^[1] ; Neelam,Sharma ^[1] ; Saurabh,Bhatia ^[2] ; Ahmed,Al-Harrasi ^[3] ; Sridevi,Chigurupati ^[2] ; Ibrahim,Alrashdi ^[4] ; Simona Gabriela,Bungau ^[5]

作者单位： Chitkara College of Pharmacy, Chitkara University, Punjab 140401, India. ^[1] Natural & Medical Sciences Research Centre, University of Nizwa, Birkat Al Mauz 616, Nizwa P.O. Box 33, Oman. ^[2] School of Health Science, University of Petroleum and Energy Studies, Dehradun 248007, India. ^[3] Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Buraydah 52571, Saudi Arabia. ^[4] Translational and Clinical Research Institute, Newcastle University, Newcastle-upon-Tyne NE1 7RU, UK. ^[5] Department of Pharmacy, Faculty of Medicine and Pharmacy, University of Oradea, 410028 Oradea, Romania. ^[6] Doctoral School of Biological and Biomedical Sciences, University of Oradea, 410073 Oradea, Romania. ^[7]

关键词 Parkinson’s disease mitochondrial dysfunction neurodegenerative diseases neuroprotection oxidative stress peroxisome proliferator-activated receptors

主题词动物(Animals);人类(Humans);神经变性疾病(Neurodegenerative Diseases);氧化性应激(Oxidative Stress);帕金森病(Parkinson Disease);过氧化物酶体增殖物激活受体(Peroxisome Proliferator-Activated Receptors)

DOI 10.3390/ijms221810161

PMID 34576325

发布时间 2023-11-01

翻译满意度评价：

准确一般字义偏差语意偏离译文作用小提交